Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Growth factors-rich plasma treatments can significantly speed up wound healing and tissue regeneration.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

An elderly Chinese man lost all his hair after taking a new heart medication.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.